Use of fluocinolone acetonide for retinal vein occlusion: A case report on the two-year outcome of the use of fluocinolone acetonide (FA) in a case of retinal vein occlusion
We present a case with a sustained 2-year effect post one FA implant. A 72-year-old male patient presented with a left hemi-retinal vein occlusion with macular oedema in January 2013. Initial treatment was intravitreal dexamethasone implants. Although he showed an excellent response, it became short lived with further retreatment, with the effect lasting for 8-10 weeks on average before oedema returned. This necessitated additional treatment with numerous anti-VEGF injections in addition to treating angiographically ischemic areas with retinal laser. At 17 months follow up, after off label use of FA, we demonstrated an improvement in both visual acuity and central subfield thickness for the patient Retinal vein occlusion is a common pathology that can be treated by various means. The off label fluocinolone acetonide (FA) implant demonstrated a sustained response over 2 years in this case. Further prospective studies of its use are needed to confirm its role in clinical practice.